International Journal of Clinical Research
International Journal of Clinical Research. 2024; 8: (11) ; 10.12208/j.ijcr.20240470 .
总浏览量: 68
昆山市第一人民医院 江苏昆山
*通讯作者: 贾彩萍,单位:昆山市第一人民医院 江苏昆山;
目的 为降低使用糖皮质激素患者的用药依从性,降低不良反应发生率,提高糖皮质激素在治疗中的安全性,对西药药学监护的效果进行分析。方法 研究择取2022年6月-2024年6月期间在本院应用糖皮质激素治疗的患者中的200例作为研究对象,依照盲选分组的方法将患者分为常规干预的对照组(100例)和西药药学监护的观察组(100例),分析西药药学监护效果。结果 观察组患者药物认知程度、用药依从性较对照组明显更高,药物不良反应发生率更低,差异P<0.05,具有统计学意义。结论 西药药学监护对使用糖皮质激素患者的临床效果显著,有效提升患者的药物认知程度及用药依从性,降低药物不良反应发生率,提高了糖皮质激素在治疗中的安全性,建议推广应用。
Objective In order to reduce the medication compliance of patients using glucocorticoids, reduce the incidence of adverse reactions, and improve the safety of glucocorticoids in treatment, the effect of western medicine pharmaceutical monitoring was analyzed. Methods: The study selected 200 patients who were treated with glucocorticoids in our hospital from June 2022 to June 2024 as the research subjects. The patients were divided into a control group with conventional intervention (100 cases) according to the blind selection grouping method) and the observation group (100 cases) of western medicine pharmaceutical care, to analyze the effect of western medicine pharmaceutical care. Results The drug awareness and medication compliance of patients in the observation group were significantly higher than those in the control group, and the incidence of adverse drug reactions was lower. The difference was P<0.05, which was statistically significant. Conclusion Western medicine pharmaceutical care has significant clinical effects on patients taking glucocorticoids. It can effectively improve patients' drug awareness and medication compliance, reduce the incidence of adverse drug reactions, and improve the safety of glucocorticoids in treatment. It is recommended to promote it application.
[1] 王科臻. 使用糖皮质激素患者的西药药学监护分析[J]. 康颐,2021(7):239.
[2] 陈谦,黄灵跃,何琦. 临床药师参与糖皮质激素停药致高热患者1例药学实践[J]. 中国乡村医药,2024,31(9):39-40.
[3] 余凤玮,谢元春,周晗菡,等. 药物相关性肝衰竭患者使用糖皮质激素治疗1例的药学监护[J]. 中国医药科学,2021,11(10):75-78,81.
[4] 梁志豪. 糖皮质激素类药物应用情况与药学干预对策分析[J]. 数理医药学杂志,2021,34(1):65-67.
[5] 牛倩倩,张静,唐崑,等. FSGS伴急性肾小管间质肾病患者1例糖皮质激素应用的分析及药学监护[J]. 临床合理用药,2024,17(7):146-148,157.
[6] 何雯,孙冬敏,牛伟,等. 我院2400张糖皮质激素类处方不合理用药分析[J]. 农垦医学,2020,42(3):271-274.
[7] 冯应聪,周辉,蔡文影,等. 临床药师对髋关节置换患者使用糖皮质激素实施药学监护的临床价值研究[J]. 当代医药论丛,2024,22(13):102-104.
[8] 冉娅娟,龙恩武,钱妍. 临床药师对1例席汉综合征患者使用糖皮质激素后出现精神异常的药学监护[J]. 实用药物与临床,2020,23(5):462-465.
[9] 刘思彤,杨烁,林平,等. 糖皮质激素类药物用药错误相关医疗纠纷的案件分析[J]. 中国医药导刊,2022,24(1):99-105.
[10] 张琴. 1例亚急性甲状腺炎患者使用糖皮质激素治疗的药学监护[J]. 海峡药学,2022,34(3):138-139.
[11] 曾燕聪,黄双英,吴娣. 临床药师参与长期使用糖皮质激素患者药学监护的效果分析[J]. 中国当代医药,2021,28(3): 17-20.
[12] 唐清云. 使用糖皮质激素患者的西药药学监护分析[J]. 医学信息,2020,33(z1):119-120.
[13] 杨殿娇. 使用糖皮质激素患者的药学监护分析[J]. 康颐,2023(2):223-225.
[14] 李佳荣,张纪岩. 糖皮质激素对免疫细胞调控的研究进展[J]. 中国免疫学杂志,2024,40(1):31-36.
[15] 林晨,张春歌,姝丽雅,等. 风湿免疫科长期口服糖皮质激素患者的知信行现状及药学监护[J]. 中国医院药学杂志,2020,40(9):1020-1026.